i-SENS, Inc. (KOSDAQ:099190)
15,900
+310 (1.99%)
Dec 30, 2025, 3:30 PM KST
i-SENS Market Cap
i-SENS has a market cap or net worth of 430.07 billion as of December 30, 2025. Its market cap has decreased by -2.01% in one year.
Market Cap
430.07B
Enterprise Value
535.27B
Revenue
313.10B
Ranking
n/a
PE Ratio
621.28
Stock Price
15,900.00
Market Cap Chart
Since January 30, 2013, i-SENS's market cap has increased from 232.76B to 430.07B, an increase of 84.77%. That is a compound annual growth rate of 4.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 430.07B | 1.90% |
| Dec 30, 2024 | 422.03B | -46.36% |
| Dec 28, 2023 | 786.74B | 74.15% |
| Dec 29, 2022 | 451.77B | 9.85% |
| Dec 30, 2021 | 411.25B | 0.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.97T |
| Celltrion | 39.67T |
| ALTEOGEN | 24.33T |
| ABL Bio | 10.99T |
| SK Biopharmaceuticals | 9.83T |
| Yuhan | 8.44T |
| HLB Co., Ltd. | 6.45T |
| LigaChem Biosciences | 6.36T |